Status:
COMPLETED
High Dose CHOP in Lymphoma
Lead Sponsor:
Rambam Health Care Campus
Conditions:
Non-Hodgkin's Lymphoma
Eligibility:
All Genders
18-65 years
Phase:
PHASE2
Brief Summary
The study hypothesis is that intensification of CHOP by dose escalation of the most active drugs in the combination will improve treatment outcome. Patients with diffuse large-cell lymphoma are treate...
Eligibility Criteria
Inclusion
- large-cell non-Hodgkin's lymphoma
- IPI low-intermediate, high-intermediate and high or bulky mediastinum
- age 18-65
Exclusion
- previous treatment for lymphoma
- serious concurrent systemic disease
Key Trial Info
Start Date :
December 1 1996
Trial Type :
INTERVENTIONAL
End Date :
September 1 2010
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT00192764
Start Date
December 1 1996
End Date
September 1 2010
Last Update
September 22 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Oncology, Rambam Medical Center
Haifa, Israel